Functional gene polymorphism of matrix metalloproteinase-1 is associated with benign hyperplasia of myo-and endometrium in the Russian population

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 9, 2012, Pages 1032-1037

  Morosova, Elena B ^a   Chukhlovin, Alexei B ^a   Kulagina, Natalia V ^b   Kipich, Natalia V ^b   Totolian, Areg A ^c  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^b NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

^c ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE;

ADENOMYOSIS; ADULT; ALLELE; ARTICLE; DISEASE ASSOCIATION; ENDOMETRIUM HYPERPLASIA; FEMALE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HYPERPLASIA; MAJOR CLINICAL STUDY; MYOMETRIUM; MYOMETRIUM HYPERPLASIA; PILOT STUDY; PROMOTER REGION; RUSSIAN FEDERATION; UTERUS MYOMA;

ADENOMYOSIS; ADULT; ALLELES; ENDOMETRIUM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERPLASIA; LEIOMYOMA; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; MYOMETRIUM; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RUSSIA; UTERINE NEOPLASMS;

EID: 84866253412     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0376     Document Type: Article

References (30)

1. Abeler M, Albores-Saavedra J, Alvarado-Cabrero I, et al. (2003) Tumors of the uterine corpus. In:Tavassoli F, Deville P (eds) Pathology and Genetics of Tumors of the Breast and Female Genital Organs. IARC Press, Lyon, pp 217-258.
2. Arena S, Zupi E (2011) Heavy menstrual bleeding:considering the most effective treatment option. Women's Health 7:143-146.
3. Blake RE (2007) Leiomyomata uteri:hormonal and molecular determinants of growth. J Nat Med Assoc 99:1170-1184. (Pubitemid 47614589)
4. Bodner-Adler B, Bodner K, Kimberger O, et al. (2004) Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors:an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. J Soc Gynecol Invest 11:182-186. (Pubitemid 38406097)
5. Borghaei RC, Gorski G, Javadi M, et al. (2009) NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter. Biochem Biophys Res Commun 382:269-273.
6. Brauer PR (2006) MMPs-role in cardiovascular development and disease. Front Biosci 11:447-478.
7. Cheng YC, Kao WHL, Mitchell BD, et al. (2009) Genome-wide association scan identifies variants near matrix metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels. Circ Cardiovasc Genet 2:329-337.
8. Curry TE Jr., Osteen KG (2003) The matrix metalloproteinase system:changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 24:428-465. (Pubitemid 37056240)
9. Fingleton B (2006) Matrix metalloproteinases:role in cancer and metastasis. Front Biosci 11:479-491.
10. Fleischer R, Weston GC, Vollenhoven BJ, et al. (2008) Pathophysiology of fibroid disease:angiogenesis and regulation of smooth muscle proliferation. Best Pract Res Clin Obstet Gynaecol 22:603-614. (Pubitemid 351804117)
11. Ghilardi G, Biondi ML, Caputo M, et al. (2002) A single nucleotide polymorphism in the MMP-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 8:3820-3823. (Pubitemid 35424775)
12. Govindan S, Shaik NA, Vedicherla B, et al. (2009) Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids. Dis Markers 26:149-154.
13. Inagaki N, Ung L, Otani T, et al. (2003) Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur J Obstet Gynecol Reprod Biol 111:197-203. (Pubitemid 37338741)
14. Jarvelainen H, Sainio A, Koulu M, et al. (2009) Extracellular matrix molecules:potential targets in pharmacotherapy. Pharmacol Rev 61:198-223.
15. McCluggage WG (2006) My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 59:801-812. (Pubitemid 44211741)
16. Montgomery GW, Nyholt DR, Zhao ZZ, et al. (2008) The search for genes contributing to endometriosis risk. Hum Reprod Update 14:447-457.
17. Pepper MS (2001) Role of the matrix metalloproteinase and plasminogen activator plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21:1104-1117. (Pubitemid 34215137)
18. Ohara N (2009) Sex steroidal modulation of collagen metabolism in uterine leiomyomas. Clin Exp Obstet Gynecol 36:10-11.
19. Othman EE, Al-Hendy A (2008) Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol 22:589-601. (Pubitemid 351804123)
20. Ouyang DW, Economy KE, Norwitz ER (2006) Obstetric complications of fibroids. Obstet Gynecol Clin North Am 33:153-169.
21. Salamonsen LA (2003) Tissue injury and repair in the female human reproductive tract. Reproduction 125:301-311. (Pubitemid 36395578)
22. Shan K, Ying W, Jian-Hui Z, et al. (2005) The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China. Mol Hum Reprod 11:423-427. (Pubitemid 41418066)
23. Shaw RW (1998) Gonadotropin hormone-releasing hormone analogue treatment of fibroids. Bailliers Clin Obstet Gynaecol 12:245-267.
24. Souslova V, Townsend PA, Mann J, et al. (2010) Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkB. PLoS ONE 5:e9902.
25. Takemura N, Yoshida S, Kennedy S, et al. (2006) Matrix metalloproteinase-1 and-9 promoter polymorphism are not associated with an increased risk of uterine leiomyomas in a Japanese population. J Soc Gynecol Invest 13:232-236.
26. Van Voorhis B (2009) A 41-year-old woman with menorrhagia, anemia, and fibroids:review of treatment of uterine fibroids. JAMA 301:82-93.
27. Ye S, Dhillon S, Turner SJ, et al. (2001) Invasiveness of cutaneous melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 61:1296-1298. (Pubitemid 34292545)
28. Zhang B, Dhillon S, Geary I, et al. (2001). Polymorphisms in matrix metalloproteinase-1,-3,-9, and-12 genes in relation to subarachnoid hemorrhage. Stroke 32:2198-2202. (Pubitemid 32868122)
29. Zhang X, Qi C, Lin J (2010) Enhanced expressions of matrix metalloproteinase (MMP)-2 and-9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding. Fertil Steril 93:2362-2367.
30. Zhou J, Brinckerhoff C, Lubert S, et al. (2011) Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors. Cancer Invest 29:599-607.